News

2025 Max Health and NZHPA Innovation Grant

05-06-2025

The award can be used to support service improvement initiatives, research projects, national or international study tours, preceptorships, international and local travel to relevant conferences.

An important update regarding registration and supply of Prochlorperazine - Prochlorperazine 3mg buccal tablets are now registered and listed on the schedule*

17-03-2025

Max Health is pleased to announce a resolution to the recent issues with Prochlorperazine 3mg buccal tablets.  Max Health Director David Pascoe, said, “in order […]

Product Launch - Stalevo® Tablets from Orion Pharma and Max Health

01-02-2025

Max Health and Orion Pharma are proud to announce the launch of STALEVO® (levodopa, carbidopa and entacapone) tablets in New Zealand. Stalevo is a pioneering […]

NEW Product Launch Modafinil 100mg Tablets from Max Health

25-11-2024

Max Health is delighted to announce the launch of Modafinil Tablets in New Zealand. Modafinil 100mg Tablets are available now and will be listed in […]

Levocarnitine 500mg capsules- Schedule Listed from 1st September

28-08-2024

Max Health’s Levocarnitine 500mg capsules are available and listed in the Pharmaceutical Schedule from Sept 1st 2024 Metabolics-brand Levocarnitine capsules are Australian made in a […]

Modafinil Tablets – New Tender Listing – Section B and Section H

26-08-2024

Max Health is pleased to announce the listing of Modafinil 100mg Tablets in Section B and H of the PHARMAC Schedule effective from the 1st […]

Max Health Innovation Grant 2024 - ENTRIES OPEN

15-08-2024

Do you have a great idea for improving patient care? Are you struggling to implement a new model of service due to lack of resources? […]

Nicorandil Tablets – New Tender Listing – Section B and Section H

15-11-2023

Max Health is delighted to announce the listing of Nicorandil 10mg and 20mg tablets in Section B and H of the PHARMAC Schedule effective from […]

Max Health Pharmacy Innovation Showcase Award 2023

10-05-2023

Max Health is proud to be supporting the annual Max Health Pharmacy Innovation Showcase Award 2023 at the upcoming NZHPA Annual Conference held in Wellington […]

New Max Health team members - welcoming Lisa Chang and Leanne Carpendale

12-02-2023

Max Health would like to extend a warm welcome to our newest team members, Lisa Chang and Leanne Carpendale. LISA CHANGCommercial Manager Lisa joined Max […]

Clinical pharmacist, Fiona McNabb wins Max Health Pharmacy Innovation Showcase Award 2022

05-12-2022

Max Health is delighted to announce clinical pharmacist Fiona McNabb as the winner of the Max Health Pharmacy Innovation Showcase Award 2022.    Fiona started […]

Levomepromazine Injection – New Tender Listing – Section B and Section H

19-10-2022

Max Health is pleased to announce the listing of Levomepromazine hydrochloride (Wockhardt) inj 25 mg per ml, 1 ml ampoule in Section B and H […]

Max Health and Hameln to launch Clindamycin 150mg/mL solution for injection into the New Zealand pharmaceutical market.

13-10-2022

Max Health is pleased to announce the upcoming launch of Clindamycin-hameln, 150mg/mL solution for injection, the newest addition to Hameln Pharma’s growing product portfolio in […]

New Schedule Listings - Alliance Pharmaceuticals

05-07-2022

In July 2021 API Consumer Brands announced its exit from the New Zealand pharmaceutical market, thus affecting the supply of a number of important products. […]

New Tender Listing – An Addition to Hameln’s Portfolio

03-04-2022

Hameln, once again, have proven their European products superior to many alternatives offered to the New Zealand market. Dexamethasone, supplied by Max Health’s German supplier […]

Partner Update – A Focus on Hameln

28-03-2022

Over the last 130 years Hameln has grown into an international supplier of generic pharmaceuticals, specialising in injectables. It boasts an impressive history, having been […]

Orion Pharma and Max Health Partnership in NZ

15-03-2022

Good afternoon,   Max Health is pleased to announce the following news regarding its partner Orion. Orion is a globally operating Finnish pharmaceutical company – […]

Octreotide Injection - New Tender Listing - Section B and Section H

09-02-2022

Max Health is pleased to confirm that is has been awarded the tender for all three strengths of Octreotide Injection – 50mcg/mL in 1mL; 100mcg/mL […]

Oxycodone Injection – New Tender Listing – Section B And Section H

03-10-2021

Max Health is happy to announce that is has been awarded the tender for all three presentations of Oxycodone Injection – 10mg/mL in 1mL; 10mg/mL […]

Neostigmine Metisulfate Injection – New Tender Listing – Section B and Section H

02-09-2021

Max Health is happy to report that is has been awarded the tender for Neostigmine Metisulfate injection 2.5mg/mL in 1mL. This product is manufactured by […]

Flumazenil Injection – New Tender Listing – Section H

01-08-2021

Max Health is pleased to announce that it has been awarded the tender for Flumazenil Injection 0.1mg/mL in 5mL. This product is manufactured by our […]

Dopamine Hydrochloride Injection – New Tender Listing – Section H

30-06-2021

Max Health is happy to announce that it has been awarded the tender for Dopamine Hydrochloride 200mg/5mL. This injection is manufactured by Martindale. Dopamine will […]

Atropine Sulphate Injection – New Tender Listing – Section H and Section B

30-06-2021

Max Health is pleased to announce that it has been awarded the tender for Atropine Sulphate 600mcg/mL. This product is manufactured by Martindale, based out […]

Max Health Announces NZ Registration of Lynley™ (Ethinylestradiol 30mcg and Levonorgestrel 150mcg) Oral Contraceptive pill

11-03-2021

Max Health is pleased to announce that it has received approval from Medsafe for the registration of Ethinylestradiol 30mcg and Levonorgestrel 150mcg (branded as Lynley™) […]

Dobutamine Injection – New Tender Listing – Section H

26-02-2021

Max Health is excited to announce that it has been awarded the tender for Dobutamine 12.5mg/mL. This product is manufactured in Germany by its trusted […]

Glycopyrronium Bromide with Neostigmine Metisulfate Injection– New Tender Listing – Section H

26-02-2021

Max Health is pleased to have been awarded the tender for Glycopyrronium Bromide 0.5mg/mL with Neostigmine Metisulfate 2.5mg/mL Injection. This product is manufactured by Martindale […]

Max Health Announces NZ Registration of Variquel (Terlipressin) Solution for Injection

24-01-2021

Max Health is delighted to announce that it has received approval from Medsafe regarding the registration of Variquel (Terlipressin) 0.2mg/mL in 5mL solution for Injection […]

Max Health Announces NZ Registration of Naltrexone Tablets 50mg

30-09-2020

Max Health is pleased to have received advice from Medsafe, that effective 01/10/2020 Naltrexone 50mg tablets are registered for use in New Zealand. This product […]

Magnesium Sulfate 2mMol/mL - New Tender Listing - Sections B & H

29-09-2020

Max Health™ is delighted to announce that it has been awarded the Tender for Magnesium Sulfate 2 mMol /1 mL. Martindale supplies Magnesium Sulfate to […]

Cyclizine Lactate 50mg/mL - New Tender Listing - Section B

31-08-2020

Max Health™ is happy to announce that it has been awarded the Tender for Cyclizine Lactate 50 mg/1 mL. Cyclizine Lactate is manufactured by Hameln […]

Alfentanil 0.5mg/mL - New Tender Listing - Section H

30-06-2020

Max Health™ is pleased to announce that it has been granted the Tender for Alfentanil 0.5 mg/1 mL. Alfentanil is manufactured Germany by Hameln Pharma […]

Metaraminol 10mg/mL - New Tender Listing - Section H

30-06-2020

Max Health™ is happy to announce that it has been given the Tender for Metaraminol 10 mg/1 mL. This product is manufactured and supplied to […]

Clarithromycin 500mg Vials - New Tender Listing - Section H

30-04-2020

Max Health™ is delighted to announce that it has been awarded the Tender for Clarithromycin 500 mg single vials. Manufactured by Martindale Pharma in the […]

Suxamethonium Chloride 50mg/mL - New Tender Listing - Section H

29-04-2020

Max Health™ is happy to announce that it has been awarded the Tender for Suxamethonium Chloride 50 mg/1 mL. This product is manufactured by Martindale […]

Max Health Announces NZ Registration of Oxycodone Solution for injection

05-04-2020

Max Health is happy to have been informed by Medsafe that as of 09/04/2020 Oxycodone 50mg/mL and Oxycodone 10mg/mL solutions for injection are registered for […]

Ephedrine 30mg/mL - New Tender Listing - Section H

27-02-2020

Max Health™ is pleased to announce that it has been awarded the Tender for Ephedrine 30 mg/1 mL. This is manufactured by Martindale Pharma in […]

Max Health Announces NZ Registration of TapClob (Clobazam) Oral Suspension

23-02-2020

Max Health is happy to announce the approval of TapClob Oral suspension for registration for use in New Zealand, as advised by Medsafe. This is […]

Max Health™ announces new product: Mevalia Low Protein Food Range

17-10-2019

Max Health™ is pleased to introduce the Mevalia range of low protein products to New Zealand. Mevalia is Dr. Schär’s range of food products with […]

Max Health™ announces NZ registration of Cyclizine injection

14-10-2019

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 17/10/2019 Cyclizine injection has been registered for use in New […]

Rocuronium Bromide 50 mg/5 mL - New Tender Listing - Section H

30-09-2019

Max Health™ is delighted to announce that it has been awarded the Tender for Rocuronium Bromide 50 mg/5 mL.   Rocuronium Bromide is manufactured by Hameln […]

Max Health™ announces NZ registration of Valganciclovir 450mg tablets

20-06-2019

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 20/6/2019 Valganciclovir 450mg tablets have been registered for use in […]

Amiodarone 150 mg/3 mL injection - New Tender Listing - Section H and Section B

29-03-2019

Max Health™ is delighted to announce that it has been awarded the Tender for Amiodarone Hydrochloride 150 mg/3 mL injection.   Amiodarone is manufactured by Hameln […]

Caspofungin 50mg / 70mg infusion - New Tender Listing - Section H

29-03-2019

Max Health™ is delighted to announce that it has been awarded the Tender for Caspofungin 50mg and 70 mg infusion.   Caspofungin is manufactured by Martindale […]

Max Health™ announces NZ registration of Amiodarone injection

28-02-2019

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 28/2/2019 Amiodarone 150mg/3ml injection has been registered for use in […]

Max Health™ announces a new collaboration with Alliance Pharmaceuticals Ltd (UK) for Ametop Topical Gel (4% W/W Tetracaine)

01-12-2018

Max Health™ is delighted to announce the signing of a new distribution agreement with Alliance Pharmaceuticals Ltd, a UK based pharma company. The first product […]

Max Health™ announces NZ registration of Caspofungin 50mg and 70mg powder for infusion

04-10-2018

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 4 October 2018 Caspofungin 50mg and 70mg powder for infusion […]

Flumazenil injection 0.1mg/ml in 5ml - New Tender Listing - Section H

11-09-2018

Max Health™ is delighted to announce that it has been awarded the Tender for Flumazenil injection 0.1mg/ml in 5ml from 1 October 2018.   Flumazenil is manufactured […]

Thiamine Hydrochloride 50mg Tablets - New Tender Listing

01-09-2018

Max Health™ is delighted to announce that it has been awarded the Tender for Thiamine Hydrochloride 50mg Tablets from 1st September 2018. Thiamine Hydrochloride 50mg Tablets […]

Dobutamine injection 250mg/20ml - New Tender Listing - Section H

06-08-2018

Max Health™ is delighted to announce that it has been awarded the Tender for Dobutamine injection 250mg/20ml.   Dobutamine is manufactured by Hameln Pharma in Germany […]

Atropine Sulfate Solution for Injection - New Tender Listing - Section B and Section H

11-07-2018

Max Health™ is delighted to announce that we have been awarded the Tender for Atropine Sulfate Solution for Injection from 1 August 2018.  Atropine Sulfate Solution […]

Sterile Dopamine Concentrate Solution for Injection - New Tender Listing

11-06-2018

Max Health™ is delighted to announce that it has been awarded the Tender for Martindale’s Sterile Dopamine Concentrate Solution for Injection from July 1st 2018.  […]

Buspirone 5mg and 10mg Tablets – Max Health Re-Awarded Sole Supply Listing

01-03-2018

Max Health™ is delighted to announce that it has been re-awarded Sole Supply Status for Buspirone 5mg and 10mg Tablets through to 30th June 2021. […]

Max Health™ Wishes All Its Customers and Partners a safe, happy Christmas and New Year

21-12-2017

2017 CPhI Conference, Frankfurt

06-11-2017

The directors of Max Health have recently returned from a pretty exhausting schedule at the CPhI Conference in Frankfurt. Some great meetings were had with […]

Max Health™ announces NZ registration of Atropine Sulphate injection

10-08-2017

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 10/08/2017 Atropine Sulphate injection has been registered for use in […]

Max Health™ announces NZ registration of Naloxone injection

29-06-2017

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 29/6/2017, Naloxone injection has been registered for use in New Zealand.  […]

Ephedrine Injection – Sole Supply Listing - Section H

28-04-2017

Max Health™ is pleased to announce that it has been re-awarded Hospital Supply Status for Ephedrine Hydrochloride Injection. The Ephedrine Injection is manufactured by Martindale […]

Clarithromycin - Sole Supply Listing - Section H

28-04-2017

Max Health™ is pleased to announce that it has been re-awarded Hospital Supply Status for Clarithromycin Injection 500mg. The Clarithromycin Powder for Injection is manufactured […]

Max Health™ announces NZ registration of Apomorphine injection

20-04-2017

Max Health™ is delighted to announce that it has received advice from Medsafe, that effective 20/4/2017, Apomorphine injection has been registered for use in New […]

Max Health™ wishes all its customers and partners a safe and happy Christmas and New Year

22-12-2016

Levomepromazine injection – Sole Supply Listing

30-04-2016

Max Health™ is delighted to announce that it has been awarded Sole Supply Status for Levomepromazine injection. Levomepromazine injection is manufactured by Wockhardt Pharmaceuticals in […]

Max Health™ achieves NZ approval of Baclofen injection

21-04-2016

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 21/04/2016, Baclofen injection has been registered for use in New […]

Max Health™ achieves NZ registration for Zoledronic Acid injection

07-04-2016

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 7/04/2016, Zoledronic Acid injection has been registered for use in […]

Max Health™ announces NZ registration of Levomepromazine injection

07-04-2016

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 7/04/2016, Levomepromazine injection has been registered for use in New […]

Milrinone Injection - Sole Supply Listing- Section H

29-02-2016

Max Health™ is pleased to announce that it has been awarded Hospital Supply Status for Milrinone Injection. The Milrinone Injection is supplied by Generic Health […]

Max Health™ announces approval of Milrinone injection in NZ

04-02-2016

Max Health™ is pleased to announce that it has received advice from Medsafe, that effective 4/2/2016, Milrinone injection has been registered for use in New […]

Buspirone 5mg and 10mg Tablets – Sole Supply Listing

18-12-2015

Max Health™ is delighted to announce that it has been awarded Sole Supply Status for Buspirone 5mg and 10mg Tablets. Buspirone 5mg and 10mg Tablets […]

Max Health™ announces NZ registration of Buspirone 5mg and 10mg tablets

10-12-2015

Max Health™ is delighted to announce the advice received from Medsafe, that effective 10/12/2015, Buspirone 5mg and 10mg tablets have been registered for use in […]

Max Health™ achieves NZ registration for Flumazenil injection

24-04-2015

Max Health™ is pleased to announce the advice received from Medsafe, that effective 24/04/2015, Flumazenil injection has been registered for use in New Zealand.  This […]

Max Health™ announces NZ registration of Neostigmine injection

19-03-2015

Max Health™ is pleased to announce the advice received from Medsafe, that effective 19/03/2015, Neostigmine injection has been registered for use in New Zealand.  This […]

International Supplier Visits

11-02-2015

Max Health™ has been very busy this month hosting visits from our key suppliers...

Ephedrine Injection – Sole Supply Listing – Section H

13-11-2014

Max Health™ has been re-awarded Hospital Supply Status for Ephedrine Injection...

Clarithromycin Powder for Injection – Sole Supply Listing – Section H

15-10-2014

Max Health™ has been awarded Hospital Supply Status for Clarithromycin Injection...

Max Health™ Award Lecture at NZHPA conference

16-09-2014

The winner of the NZHPA Max Health™ Pharmacy Grant for 2013...

Max Health™ congratulates Germany for their success in the 2014 FIFA World Cup

15-07-2014

The staff at one of our key suppliers, Hameln Pharma, based in Germany, are understandably delighted with the performance of their national team! Hameln supplies […]

Alfentanil Hameln Injection – Sole Supply Listing – Section H

14-05-2014

Max Health™ has been awarded Hospital Supply Status for Alfentanil Hameln 1mg/2ml Injection...

New Registration – Alfentanil Hameln 1mg/2ml Injection

16-04-2014

Distribution of Alfentanil Hameln injection and all other Max Health™ products is handled by OneLink...

New Zealand Pharmacy Technicians Special Interest Group Meeting – Saturday 15th March

11-02-2014

Max Health™ is delighted to be sponsoring the Pharmacy Technicians Special Interest Meeting

NZHPA Max Health™ Pharmacy Grant Winner Announced

16-10-2013

The NZHPA Max Health™ Pharmacy Grant for 2013 has been awarded to Avril Lee

Approval of Glycopyrronium 0.5mg/ml and Neostigmine 2.5mg/ml injection

17-07-2013

Max Health™ has just been advised by Medsafe that, effective 11 July 2013 the combination injection of Glycopyrronium and Neostigmine (from Martindale) has been registered.

Glycopyrronium bromide injection – Sole Supply Listing - Section H

03-07-2013

Max Health™ has been awarded Hospital Supply Status for Glycopyrronium bromide Injection...

Magnesium Sulphate injection - New Tender Listing - Section H and Section B

15-11-2012

Max Health™ has been awarded Hospital Supply Status for Magnesium Sulphate Injection...

Oxycodone Injection- New Sole Supply and Hospital Supply information

20-09-2012

Max Health™ has been awarded Sole Supply and Hospital Supply Status...